Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/15072
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaen-Oon S.
dc.contributor.authorKuno H.
dc.contributor.authorHannongbua S.
dc.date.accessioned2021-04-05T04:32:29Z-
dc.date.available2021-04-05T04:32:29Z-
dc.date.issued2005
dc.identifier.issn8873585
dc.identifier.other2-s2.0-28644442414
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/15072-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-28644442414&doi=10.1002%2fprot.20690&partnerID=40&md5=bdfa20e816813bf3ae48971687134dd4
dc.description.abstractTwo-layered and three-layered ONIOM calculations were performed to compare the binding energies of 8-Cl TIBO inhibitor when bound into the human immunodeficiency virus reverse transcriptase binding pocket and a Y181C variant. Both consisted of 20 residues within a radius of 15 Å. A combination of different methods [HP2/6-31G(d), B3LYP/6-31G(d,p), and PM3] were performed to take advantage of ONIOM's layering strategy analysis. The obtained results clearly indicate that the Y181C mutation reduces the binding affinity and stability of the inhibitor by approximately 8-9 kcal/mol as obtained from different combined MO:MO methods. Analyses regarding the energetic components of the interaction and deformation energies for 8-Cl TIBO inhibitor upon binding were also examined extensively. Additional calculations involving the interaction energies between 8-Cl TIBO with individual residues surrounding the binding pocket were performed at MP2/6-31G(d,p) and B3LYP/6-31G(d,p) levels of theory to gain more insight into the energetic differences of wild-type and Y181C mutant type at the atomistic level. © 2005 Wiley-Liss, Inc.
dc.subject4,5,6,7 tetrahydroimidazo 8 chloro 5 methyl (3 methyl 2 butenyl)imidazo
dc.subjectRNA directed DNA polymerase
dc.subjectRNA directed DNA polymerase inhibitor
dc.subjectunclassified drug
dc.subjectanalytic method
dc.subjectarticle
dc.subjectbinding affinity
dc.subjectcalculation
dc.subjectcomparative study
dc.subjectcomplex formation
dc.subjectdrug binding site
dc.subjectdrug protein binding
dc.subjectenergy
dc.subjectHuman immunodeficiency virus 1
dc.subjectmolecular stability
dc.subjectmutation
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectquantum chemistry
dc.subjectwild type
dc.subjectAmino Acid Substitution
dc.subjectDimerization
dc.subjectHIV-1
dc.subjectKinetics
dc.subjectModels, Molecular
dc.subjectPolymorphism, Single Nucleotide
dc.subjectProtein Structure, Secondary
dc.subjectProtein Subunits
dc.subjectQuantum Theory
dc.subjectRecombinant Proteins
dc.subjectReverse Transcriptase Inhibitors
dc.subjectRNA-Directed DNA Polymerase
dc.subjectThermodynamics
dc.subjectHuman immunodeficiency virus
dc.subjectHuman immunodeficiency virus 1
dc.titleBinding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationProteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869
dc.identifier.doi10.1002/prot.20690
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.